Search alternatives:
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
961
-
962
-
963
Alternative performance measures versus and as a function of .
Published 2024“…This figure shows that <i>G</i><sub><i>C</i></sub> and <i>G</i><sub><i>H</i></sub>, but not , decreases a bit with .</p>…”
-
964
Fenretinide decreases levels of PAX3/FOXO1 and its target genes in aRMS cell lines.
Published 2013“…D) Fenretinide did not decrease mRNA levels of FOXO1 in aRMS cells. qRT–PCR was carried out after treatment with an IC<sub>50</sub> concentration of fenretinide during different time points (24–48–72 hours). …”
-
965
-
966
-
967
-
968
Pre-treatment with CDDO-Me decreases IR-induced DNA damage in a variety of non-cancerous cells.
Published 2014“…Data analyzed and calculated using Open Comet software [tail moment = tail length x tail DNA percentage]. Mean ± SEM of >50 cells per condition, *p<0.05 using t-test (compared to 3 Gy DMSO). …”
-
969
-
970
-
971
-
972
Decreased remyelination initiation is observed in Scribble cKO mice following focal demyelination in corpus callosum.
Published 2015“…<i>n</i> = 3 mice per genotype. * <i>p</i> < 0.05, ** <i>p</i> < 0.01, *** <i>p</i> < 0.001 versus Scrib WT CL. Scale bars: A,B,D,E: 2 μm. J,K: 50 μm.</p>…”
-
973
-
974
-
975
-
976
-
977
-
978
-
979
Immunodepletion assays of S100A6 and S100A11.
Published 2008“…<p>Normalized ProteinChip® array profiles of metastatic tissue show that the peaks representing S100A6 (A, 10.162 kDa) or S100A11 (B, 12.009 kDa) were detectable in the negative controls but only with decreased intensity with the corresponding depleted probes. …”
-
980
Rapamycin inhibits mTOR and decreases Aβ<sub>42</sub> levels in brains of PDAPP mice.
Published 2013“…<b>d</b>, rapamycin did not alter Aβ<sub>40</sub> levels but significantly decreased soluble Aβ<sub>42</sub> levels in the brains of transgenic PDAPP mice *, <i>P</i> = 0.02. …”